| 麦吾兰·托胡提,阿不力米提·买买提,张文涛,蔺益红,买尔旦·阿不来.对比分析局部枸橼酸抗凝与全身低分子肝素抗凝在重症结核病患者 CRRT中的临床效果与安全性[J].,2024,(20):3900-3902 |
| 对比分析局部枸橼酸抗凝与全身低分子肝素抗凝在重症结核病患者 CRRT中的临床效果与安全性 |
| Comparative Analysis of Clinical Efficacy and Safety of Local Citrate Anticoagulation and Systemic Low-molecular-weight Heparin Anticoagulation in CRRT of Patients with Severe Tuberculosis |
| 投稿时间：2024-03-13 修订日期：2024-04-10 |
| DOI：10.13241/j.cnki.pmb.2024.20.025 |
| 中文关键词: 局部枸橼酸抗凝 全身低分子肝素抗凝 重症结核病 连续性肾脏替代治疗 |
| 英文关键词: Local citrate anticoagulation Whole body low molecular weight heparin anticoagulation Severe tuberculosis Continuous renal replacement therapy |
| 基金项目:省部共建中亚高发病成因与防治国家重点实验室开放课题项目（SKL-HIDCA-2021-BF6） |
|
| 摘要点击次数: 22 |
| 全文下载次数: 16 |
| 中文摘要: |
| 摘要 目的：对比分析局部枸橼酸抗凝与全身低分子肝素抗凝在重症结核病患者连续性肾脏替代治疗（CRRT）中的临床效果与安全性。方法：选取我院2021年10月到2023年9月60例采取CRRT治疗的重症结核病患者，分为观察组（局部枸橼酸抗凝）与对照组（全身低分子肝素抗凝），各30例。对比两组的血常规、肝肾功能指标、预后水平，及并发症。结果：治疗后两组患者PLT水平均降低，INR、APTT水平均升高，具有统计学意义（P＜0.05）；治疗后两组患者Scr、BUN水平、SOFA、APACHEⅡ评分均降低，且观察组与对照组比较有差异（P＜0.05）；观察组过滤器使用寿命高于对照组，出血发生率低于对照组（P＜0.05）。结论：针对重症结核病患者采取局部枸橼酸抗凝效果较好，同时采取局部枸橼酸抗凝可在提升抗凝效果的同时，改善肾功能，改善患者预后水平，提升过滤器使用寿命，降低出血发生率。 |
| 英文摘要: |
| ABSTRACT Objective: To compare the clinical efficacy and safety of local citrate anticoagulation and systemic low-molecular-weight heparin anticoagulation in CRRT for patients with severe tuberculosis. Methods: From October 2021 to September 2023, 60 patients with severe tuberculosis who were treated with CRRT in our hospital were selected and divided into the observation group (local citrate anticoagulation) and the control group (systemic low-molecular-weight heparin anticoagulation), 30 patients in each group. Compare the blood routine, liver and kidney function indicators, prognosis level, and incidence of complications between the two groups. Results: After treatment, PLT levels decreased in both groups of patients, while INR and APTT levels increased, with statistical significance (P<0.05); After treatment, the Scr, BUN levels, SOFA, and APACHE II scores of both groups of patients decreased, and there was a significant difference between the observation group and the control group (P<0.05); The service life of the observation group filter was higher than that of the control group, and the incidence of bleeding was lower than that of the control group (P<0.05). Conclusion: For severe tuberculosis patients, local citrate anticoagulation is better, while local citrate anticoagulation can improve the renal function, improve the prognosis of patients, improve the service life of the filter, and reduce the incidence of bleeding. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
